In summary, we have showed for the first time that the axon guidance factor SEMA3F was expressed in endocrine cells of the intestinal epithelium and was lost in neuroendocrine tumors arising in the distal small intestine, according to the stage. This evidence concerns the gene SEMA3F and neuroendocrine neoplasm.